Skip to content
Zanteris - Logo
  • Home
  • Company
    • Our Values
    • Our Approach
    • Areas of expertise
    • About us
    • Resources
  • Solutions
    • Clinical Operations Consulting
    • Clinical Project Management Resources
    • Human Efficiency Consulting
    • Strategic Partnerships
  • Insights
  • Contact
Menu
  • Home
  • Company
    • Our Values
    • Our Approach
    • Areas of expertise
    • About us
    • Resources
  • Solutions
    • Clinical Operations Consulting
    • Clinical Project Management Resources
    • Human Efficiency Consulting
    • Strategic Partnerships
  • Insights
  • Contact
Clinical Research Trends in The Pharmaceutical Industry | Zanteris
March 29, 2023

Clinical Research Trends in The Pharmaceutical Industry

In 2023, the clinical trial market is set to enter a brand-new period of potential. Opportunities to improve productivity in all phases of clinical trials are greater than they have ever been thanks to the proliferation of game-changing technology and the advent of widespread process automation. How will innovations like hybrid trials and more sustainable site practices affect the future of clinical research? What can we anticipate from clinical trials this year? Let's take a look at some possible outcomes.

Prioritizing workflow integration to shorten research times.

There has been an uptick in the availability of eClinical technology instruments for use in clinical trials in recent years. Interoperability and workflow integration amongst technologies across the lifecycle may improve trial operations, build confidence among stakeholders, and ultimately eliminate white space.

 

The trial financing and grant payment procedures are two examples of issues that have been handled separately in the past. Cycle durations and the chance of contract revisions can be significantly decreased, allowing for the "first patient in" to be reached sooner through the automation and integration of the relevant operations. It is the time to take advantage of the chance to hasten the beginning of the research.

 

Leveraging Big Data

The clinical trial sector has always relied heavily on information and understanding to enhance the procedure of medication development. Yet this year, businesses are anticipated to place an even greater emphasis on using big data and data science to improve budgeting, forecasting, and risk assessment. But, there are also attempts made to zero in on ways to improve our knowledge of genuine patient expenses and have a real effect on patient acquisition and retention. Clinical trial sponsors are forecasted to place a premium on collaborating with solutions and services that can offer not just cutting-edge analytics but also suppliers with real, up-to-date data that may give novel avenues for enhanced business intelligence and competitive advantage [1].

 

Flexibility

While Decentralized Clinical Trials (DCTs) have garnered a lot of interest in recent years, 2023 will see a trend toward greater participant flexibility. As a result, I think there will be a stronger bond between sites and participants than ever before. Although sites will still play a crucial role in the success of studies, participants will have more freedom in deciding how they want to participate.

 

Sites can better take charge of patients' lives outside of treatment if they are provided with resources to aid them in their digital journey. As a sector, we can also work to strengthen recruiting efforts, boost engagement, and enhance retention, all of which will contribute to the optimization of trials as a whole.

Relieving Site Frustrations

We must be careful that our efforts to improve patients' schedule flexibility do not lead to an increase in either site burden or expenditures.

 

Clinical research sites have faced the painful pinch of growing inflation, residual consequences of the COVID-19 epidemic, and personnel issues, requiring them to accomplish more with less. Especially with the addition of new staff members who should prioritize spending time caring for research participants, it is crucial that the site staff have easy-to-use tools and the skills they need to do their work efficiently and successfully.

 

A recent Greenphire poll indicated that sites, sponsors, and CROs all agreed that automating site payments is the #1 technological trend to improve site interactions, confirming the trend toward a more financial focus [2].

 

Despite having only three months' worth of operational funds on hand in 2022, only 56% of sites negotiated monthly payment arrangements with research sponsors. In 2023, with an influx of new trials, we anticipate the industry will coalesce with sites to guarantee they are supported to do their tasks in the midst of economic volatility. Sites seek partners that will assist them in doing their jobs better [3].

 

Increased Sustainability

Increased Sustainability Technology advancements will link and streamline workflows, allowing industry stakeholders to better manage their resources and provide more reliable and effective research results. With the use of virtual technologies and remote patient monitoring devices, more information may be gathered and shared.

 

As we near the end of the first quarter of 2023, it is important to note that the clinical trials sector will expand and evolve during the year. The use of digital technology, the collection and analysis of large amounts of data, and the provision of trial-related choices to participants will keep playing important roles. These are just some of the developments that we see impacting clinical trials in the future year; what else should we be out for?

 

Full-Service Clinical Trial Management at Zanteris

Being a top Clinical Research Organization (CRO), Zanteris is an industry leader in functional clinical research. Zanteris provides pharmaceutical and biotechnology companies with a solution for managing all parts of a clinical trial with its complete clinical research study management. Organizations can save time and money by using Zanteris to standardize their clinical trials, collect better data, and boost productivity.

References:

  1. https://greenphire.com/news/new-global-survey-reveals-shift-in-clinical-trial-priorities-payment-efficiencies-emerge-as-leading-concern-for-sponsors-cros-and-sites/
  2. https://www.forbes.com/sites/sap/2023/02/20/life-sciences-trends-2023-clinical-research-trials-at-your-local-pharmacy/?sh=1526d16268dd
  3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2760326/

 

Featured Insights

Loading...
Factors To Consider In Making a Clinical Research | Zanteris
May 25, 2022

Factors To Consider In Making a Clinical Research

Clinical Research is being done to extrapolate, explain, and explore various medical concerns through data and experimentation. Basically, the objective...
READ MORE
Keys To Success With Clinical Trials
May 25, 2022

Keys To Success With Clinical Trials

Clinical Trials is a specialized area of study that faces an ever-changing environment. The shifts in this field are happening...
READ MORE
doctor holding a phone | Zanteris
May 25, 2022

The Challenges of Clinical Research

Working in a Clinical Project is challenging but rewarding. It also requires the support of many different stakeholders. These include...
READ MORE

What It’s Like Working With Us

… a good sense of what it takes to successfully navigate challenging clinical trials to achieve success on behalf of his customers. In particular, his data and information expertise gave him the ability to mentor, support and coach teams towards a more data driven approach to strategy and outcomes. …

Senior Vice President

Clinical Informatics US
CRO Company

  • Privacy policy
  • Cookie policy
  • Legal notice
  • General terms
  • Terms of use
  • Privacy policy
  • Cookie policy
  • Legal notice
  • General terms
  • Terms of use
©2023 Zanteris – All Rights Reserved
  • Privacy policy
  • Cookie policy
  • Legal notice
  • General terms
  • Terms of use
  • Privacy policy
  • Cookie policy
  • Legal notice
  • General terms
  • Terms of use
Scroll Up

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Zanteris - favicon
Powered by  GDPR Cookie Compliance
Privacy Overview

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Cookies strictly necessary

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms.    You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

If you set your browser to block or alert you about these cookies, but some parts of the site will not then work.

3rd Party Cookies

This website uses Google analytics cookies to store unique user data in order to get detailed data over how users use and navigate on the website.

We also use social media buttons on our site which allow you to share content and interact with your social network on platforms like Linkeldin and Twitter. These social media platforms may set their own cookies on your device. We do not control the settings of these cookies so we suggest you check the social media website for more information about their cookies and how to manage them.

If you'd like us to improve our website, please keep this cookie activated.

Please activate the "cookies strictly necessary"; so, we can record your choice!